Agenus | AGEN - 应收帐款人



金融业
股票价格
USD
资产
USD 172.69M
现金及等价物
USD 18.74M
销售成本
USD 642K
流动资产
USD 78.81M
流动负债
USD 231.82M
债务
USD 35.54M
股息收益率
0
EBIT
USD 15.05M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD 1.02
股本和储备
USD -199.08M
销售毛利
USD 33.74M
债务利息支出
USD 14.67M
贷款资金
USD 153.99M
市值
USD 2.95B
净收入
USD 39.17M
营业费用
USD -199.08M
营业利润
USD 15.05M
普通股股本
USD 38.52M
PE价格收益
17.82
税前利润
USD 39.21M
销售收入
USD 33.7M
销售和管理费用
USD 6.21M
贸易债权人
USD 58.98M
应收帐款人
USD 22.34M


应收帐款人 更改 日
AbbVie USD 12.48B 110M 2026-03
Agenus USD 22.34M 107K 2026-03
Amgen USD 10.23B 1.09B 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Celldex Therapeutics USD 230K 0 2026-06
CSL USD 4.32B 1.35B 2025-12
Eli Lilly USD 23.48B 2.3B 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Glaxosmithkline GBP 10.49B 40.6M 2026-03
Incyte USD 1.13B 73.7M 2026-06
Intrexon USD 1.02M 559K 2024-06
J&J USD 22.54B 1.21B 2026-03
Jiangsu Hengrui CNY 6.51B 569.71M 2026-03
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
Merck EUR 4.95B 139M 2026-06
Merck USD 12.21B 435M 2026-03
Northwest Biotherapeutics USD 311K 299K 2025-09
Novartis USD 9.85B 252M 2026-06
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 16.19B 19M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 54.18M 4.06M 2026-06